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Background Suitably qualified non-medical healthcare professionals may now prescribe 
medicines. Prescribing decision-making can be complex and challenging; a number of 
influences have been identified among medical prescribers but little appears to be known 
about influences among non-medical prescribers (NMPs).  
Objective To critically appraise, synthesize and present evidence on the influences on 
prescribing decision-making among supplementary and independent NMPs in the United 
Kingdom. 
Methods The systematic review included all studies between 2003 and June 2013. 
Included studies researched the prescribing decision-making of supplementary and 
independent NMPs practising in the UK; all primary and secondary study designs were 
considered. Studies were assessed for quality and data extracted independently by two 
researchers, and findings synthesised using a narrative approach. 
Results Following duplicates exclusion , 886 titles, 349 abstracts and 40 full studies 
were screened. Thirty-seven were excluded leaving three for quality assessment and 
data extraction. While all studies reported aspects of prescribing decision-making this 
was not the primary research aim for any. Studies were carried out in primary care 
almost exclusively among nurse prescribers (n=67). Complex influences were evident 
such as experience in the role, the use of evidence-based guidelines and peer support 
and encouragement from doctors; these helped participants to feel more knowledgeable 
and confident about their prescribing decisions. Opposing influences included 
prioritisation of experience and concern about complications over evidence base, and 
peer conflict. 
Conclusion While there is a limited evidence base on NMPs’ prescribing decision-
making, it appears that this is complex with NMPs influenced by many and often 






Suitably qualified non-medical healthcare professionals, largely nurses and pharmacists, 
may now prescribe medicines for their patients. Non-medical prescribing has developed 
according to different models across the world, reflecting different healthcare systems (1, 
2, 3, 4, 5). Nurse prescribing has been implemented in the United States of America (USA), 
Canada, Australia, New Zealand, the Republic of Ireland, Finland, Sweden, the 
Netherlands, Spain, and the United Kingdom (UK) although frameworks within which this 
occurs vary markedly (1, 6). Pharmacists have prescribing authority in Canada, USA, New 
Zealand and the UK (7, 8); again the model varies.   
 
Notwithstanding this variation, development of non-medical prescribing across the world 
has been driven by a desire to improve access to medicines, sometimes in response to 
geographical isolation, to improve the quality of care and to make best use of healthcare 
professionals’ skills (6, 9). In most countries, non-medical prescribers (NMPs) work in 
collaboration with a supervising doctor to treat patients for previously-diagnosed or pre-
specified conditions (5, 9, 10). In the UK and certain other countries additionally qualified 
NMPs practise within their competence as independent prescribers responsible for patient 
care including diagnosis and prescribing from largely the same range of medicines as 
doctors across a wide range of acute, chronic and complex conditions in primary and 
secondary care (10,11). In the UK ‘community practitioner nurse prescribers’ prescribe 
from a restricted range of products, primarily wound dressings and products for minor 
ailments and symptomatic relief. The mode and scope of their practice is very limited, as 
was that of extended formulary nurse prescribers; this role ceased in 2006 with the 
implementation of independent nurse prescribing.  These categories of nurse prescribers 
fall out with the definition of ‘supplementary and independent prescribers’ in the UK 
legislative prescribing framework. There are plans to extend both the range and scope of 




Whatever the profession, practice setting or clinical area, prescribing decision-making is 
a key skill for all prescribers. It is one of the cornerstones of patient safety (15) and, like 
all decision-making, can be challenging. In addition to clinical aspects, prescribers’ and 
patients’ health beliefs and behaviours are influential. Newell and Simon (16) described 
problem solving as a step-wise process of iterative hypothesis development and testing, 
moderated by the application of heuristics (i.e. a practical method not intended to be 
optimal or perfect) and/or algorithms informing the development of a plan. The process 
is evaluated and a final proposed solution arrived at and again tested for suitability. This 
model may be applied to prescribing decision-making where ‘heuristics’ may be 
considered to equate to prescribers’ attributes and experiences, and clinical guidelines 
may approximate to ‘algorithms’. Research into doctors' prescribing decision-making, 
mainly in primary care, has identified the importance of both types of influences with on-
going debate about their relative significance (17, 18). In 1992 Bradley published a critical 
incident study on ‘uncomfortable’ prescribing decisions among general practitioners 
(GPs) in England, providing evidence that their decisions were based on a variety of 
clinical and non-clinical influences including patient expectations, the doctor-patient 
relationship and the doctor's previous behaviour (17). GPs' discomfort around some of 
their prescribing decisions was multifactorial. This seminal paper acted as a stimulus to 
further qualitative research (19, 20, 21, 22, 23, 24, 25, 26, 27).  
 
Prescribing decision-making is therefore clearly complex and challenging; a number of 
influences have been identified among medical prescribers but little appears to be known 
about such influences among NMPs. There is limited evidence regarding non-medical 
prescribing decision-making although it has been evaluated as safe across a range of 
settings (28, 29, 30, 31). NMPs assert that they adhere strictly to evidence-based practice (28), 
yet this may not always be the case (32, 33). NMPs have disparate professional backgrounds 
but unlike doctors, none comes from a tradition of sometimes paternalistic relationships 
with patients or from a position at the top of the healthcare hierarchy (34, 35). It may be 
that their prescribing decisions are informed by different or additional influences to those 
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of doctors. It is essential that their prescribing decision-making processes are 
understood so that they may be optimised for patients' benefit. Systematic reviews 
constitute the highest level of evidence (36); a search in eight appropriate databases 
found no systematic review in this area. The aim of the systematic review was to 
critically appraise, synthesise and present the evidence on influences on prescribing 
decision-making among supplementary and independent NMPs in the UK. Given the 
variation in cultures, health systems and non-medical prescribing practice across the 
world the review was restricted to studies examining practice in the UK.  
 
METHODS 
The systematic review protocol development was informed by standard guidance (37) and 
registered with PROSPERO at the Centre for Reviews and Dissemination, University of 
York, United Kingdom (registration number CRD42013004729). 
 
Inclusion criteria 
Studies researched the prescribing decision-making of supplementary and independent 
NMPs practising in the UK. All primary and secondary study designs were considered, 
with searching limited to articles published from 2003, the start of implementation of 
non-medical prescribing in the UK, to June 2013.  
 
Exclusion criteria 
Studies focusing on the administration or supply of medicines via patient group 
directions were excluded, as were abstracts, conference proceedings, editorials and 
letters. Multi-professional studies where no data were reported according to participants' 
professions were also excluded.  
 
Search strategy 
The following databases were searched: Cumulative Index to Nursing & Allied Health 
Literature (CINAHL), Education Resources Information Centre (ERIC), Google Scholar, 
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International Pharmaceutical Abstracts, Medline, PsycARTICLES, and The Cochrane 
Library. Search terms were: prescrib* and (pharmacist* or nurse* or physiotherapist* or 
podiatrist* or radiographer* or optometrist*) and (influenc* or decision* or decid* or 
judge* or factor*). References lists were scrutinised and any additional relevant titles 
included. During title, abstract and full paper screening, inter-rater reliability was 
confirmed by two independent researchers (TM and one other of SC, DS and KFM) 
comparing a random sample of 10% of titles, abstracts and full papers. 
 
Quality assessment, data extraction and synthesis 
Studies were assessed for quality using a standard tool (38); quality assessment was 
carried out independently by two researchers (TM and one other of SC, DS and KFM) and 
any disagreements resolved by discussion. A data extraction tool was prepared, piloted 
and used according to the review protocol; data extraction was conducted independently 
by two researchers, as described above. Review findings were synthesised using a 
narrative approach.  
 
Outcomes 
The primary outcome identified influences on prescribing decision-making by non-
medical prescribers; secondary outcomes included their management of otitis media and 
respiratory tract infections and their pharmacological knowledge and decision-making. 
Given the small number of papers retrieved it was decided not to exclude any based on 
quality.   
 
RESULTS  
Following exclusion of duplicates, 886 titles, 349 abstracts and 40 full studies were 
screened sequentially. Thirty-seven studies were excluded for the following reasons: no 
NMP prescribing decision-making described (n=27); included only extended formulary 
nurse prescribers (n=3); setting outwith the UK (n=2); while published post 2003, 
recruitment of study participants pre-2003 (n=2); and medical and non-medical 
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prescribers not differentiated in reporting of results (n=3). The PRISMA flow diagram is 
given in Figure 1 (39). 
 
[Insert Figure 1.] 
 
Quality assessment was conducted on the three remaining studies, all of which employed 
qualitative methodologies, as described in Table 1. Key strengths of the studies included 
the justification and appropriateness of the qualitative approaches and corresponding 
study designs. Two of the studies provided clear statements of study aims (32, 33); this 
was absent in the third (40). Study limitations were: a general lack of detail over 
recruitment strategies and processes (e.g. one study described purposive sampling but 
with no further details of strata (40); no justification of sample size and consideration of 
saturation; and the absence in two of the studies of any theoretical underpinning in the 
construction of the data generation tools and data analysis (32, 33). The third study (40) 
applied to Hammond’s Cognitive Continuum Theory which places the cognitive activities 
of decision-makers into six broad categories: scientific experiment; controlled trial; 
quasi-experiment; system aided judgement; peer-aided judgement; and intuitive 
judgement (41). 
 
[Insert Table 1.] 
 
Despite study limitations all were included in data extraction, results of which are 
provided in Table 2. While all studies reported aspects of prescribing decision-making, 
this was not the primary research aim for any. The aims centred around: use of evidence 
based guidelines in the management of otitis media (32); experience of consultations for 
respiratory tract infections (33); and exploring pharmacological knowledge and decision-
making around given scenarios (40). Studies were carried out in primary care almost 
exclusively among nurse prescribers (n=67); only one pharmacist prescriber and one 
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physiotherapist prescriber were included in one focus group and results from the focus 
group were not differentiated according to profession (33).    
 
[Insert Table 2.] 
 
Philp and Winfield studied nurse prescribers treating otitis media in children. While 
participants reported valuing and using evidence-based guidelines to inform their 
prescribing decision-making, they felt that guidelines were not appropriate in all 
circumstances and sometimes prioritised their experience over guidelines when 
prescribing antibiotics. Prescriber concerns about possible clinical complications were 
reported as sometimes being more influential; these concerns were due to external 
factors such as practice setting including out of hours and time-pressured clinics, patient 
specific factors and parental pressure. All participants had been aware of parental 
pressure to prescribe antibiotics which they considered to be inappropriate. While 
experience, confidence and colleague support were helpful in resisting this pressure,  
most reported having prescribed antibiotics against guideline recommendations as a 
result of external influences (32). 
 
Offredy and colleagues used previously validated clinical scenarios to score participants’ 
pharmacological knowledge and data generated via semi-structured interviews were 
used to ascribe participants’ decision-making to one of six modes according to 
Hammond’s Cognitive Continuum Theory (41). Participants were also asked to rate their 
knowledge and confidence of medication used in their area of practice and about 
medication-related issues. More patient contact increased participants' comfort with 
prescribing decision-making. Some participants indicated that the availability of 
extensive peer and organisational support influenced their prescribing. Participants’ 
knowledge of pharmacology was poor; most could not respond appropriately to the 
scenarios but said that in general they would access the British National Formulary 
before making prescribing decisions. Participants who were unable to respond to 
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scenarios said they would refer the ‘patient’ to the general practitioner as the situations 
were outwith their experience and competence. Most participants rated themselves as 
confident in dealing with medication-related issues. Participants’ prescribing decision-
making was categorised by the researchers as involving moderately-strong or weak 
quasi-rational thought although the method by which this was done was not always 
justified.  
 
Rowbotham and colleagues (33) studied NMPs’ experiences of managing patients with self-
limiting respiratory tract infections. NMPs reported that while some patients consulted 
seeking reassurance that their condition was not serious, others wanted (or sometimes 
demanded) treatment with antibiotics, generally due to a lack of understanding of the 
condition and/ or previous treatment with antibiotics. Consultations could be time 
consuming and complex and participants worried about misdiagnosis, leading to a 
cautious approach to prescribing decision-making. Some had prescribed antibiotics in the 
past in response to time pressure, adverse social circumstances and patient expectation 
and/or clinical uncertainty but most said that they would no longer do so. Patient 
education and good communication skills were considered important and peer support 
and the use of guidelines helpful in resisting patient pressure for antibiotics however 
some nurse prescribers reported conflict with GPs who prescribed antibiotics after a ‘no 
antibiotic’ decision by the nurse prescriber. 
 
DISCUSSION 
This systematic review has identified a paucity of research around NMPs’ prescribing 
decision-making with only three studies meeting the inclusion criteria. Furthermore, 
exploring and articulating NMPs’ prescribing decision-making was not the primary aim of 
any of the studies reviewed. The limited evidence from this systematic review, however, 
suggests that NMPs perceive prescribing decision-making as challenging and complex. 
Experience in the role (32), the use of evidence-based guidelines (32, 33) and peer support 
and encouragement from doctors (40) helped participants to feel more knowledgeable and 
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confident about their prescribing decisions, and also to resist patient pressure for 
antibiotics (34). Evidence-based guidelines were useful in helping NMPs to resist this 
pressure (33).   
 
This is the first systematic review to focus on influences on prescribing decision-making 
by non-medical prescribers and reveals differences from what is known about medical 
prescribers. Transferability of review findings may be limited by small sample sizes, UK 
primary care settings and inclusion of almost exclusively nurse prescribers. Furthermore, 
all three studies focused on prescribing decision-making for acute conditions and hence 
the findings are not necessarily transferable to decision-making for patients with chronic 
conditions or instances of multimorbidity.  
 
Only a small number of NMP studies were available for inclusion within this systematic 
review, however it is evident from these and research involving prescribing within the 
medical field that prescribing decision-making is complex and influenced by many 
factors, some of which may be contradictory and complicate further decision-making. 
This complexity aligns to the step-wise process of hypothesis development and testing 
described by Newell and Simon (16). At this stage, in view of the small number of studies 
the influences identified among NMPs should be interpreted and utilised with caution. It 
is vital that more high quality research is carried out to explore them further. One 
limitation of the studies in this review is that none described fully the process of 
decision-making leading to the development of a prescribing plan with subsequent 
evaluation and solution definition. Notably, none of the studies identified as paramount 
the key social and cognitive influences which have been described for medical 
prescribers, among whom the doctor-patient relationship and perceived patient/ parental 
pressure were found to be highly influential (20, 21, 22, 25, 42,  43, 44, 45, 46, 47).  However, 
among NMP prevalent influences were clinical uncertainty including potential risk of 




Algorithms, in the form of evidence based guidelines, influenced prescribing decision-
making by non-medical prescribers and were perceived to offer rigorous, clear guidance 
on treatment and selection of antibiotics for otitis media and respiratory tract infections 
(32, 33). While most participants claimed to follow such guidelines, some more experienced 
NMPs described a more heuristic approach to management during which they had 
chosen to ignore guidelines, and sometimes practice policy, and prescribe antibiotics in 
response to clinical uncertainty and perceived risk of complications (32, 33). They also 
prescribed antibiotics in response to external factors such as previous experience, 
perceived patient pressure for antibiotics, patients’ socio-economic status and 
prescriber’s knowledge of the patient or family (32, 33). Prescribing decision-making for 
self-limiting infections can also be challenging for medical prescribers and there is wide 
variation in antibiotic prescribing (48). Antibiotic stewardship is a key public health 
concern world-wide (49); it is important that all prescribers follow best practice in this 
area yet there is ample evidence that this is not happening with potentially serious 
implications for the future (50, 51). 
 
The heuristic approach was also apparent in relation to NMPs relying on intuition and 
experience when responding to clinical scenarios, rather than on up to date 
pharmacological knowledge. Offredy and colleagues identified poor knowledge despite 
participants claiming knowledge of medicines used in their own clinical areas. (40). Others 
have highlighted that practising NMPs have identified a need for continuing professional 
development in the area of pharmacology and drug interactions (52). 
 
The context within which prescribing occurred was important in influencing prescribing 
decision-making; a team approach to prescribing with peer support and encouragement 
from doctors helped to build participants’ confidence (40) and helped them to resist 




Further research on NMPs’ decision-making processes is warranted using qualitative 
approaches such as interviews and focus groups with rigour to provide trustworthiness 
and transferable findings. Quantitative methodologies such as widely-disseminated 
questionnaires should provide generalisable results around the extent of cognitive and 
social issues which could inform education and training. There is also a need to explore 
the impact of these on prescribing decisions made and the clinical implications, perhaps 
through case studies. 
 
In conclusion, this high quality systematic review shows that while there is a limited 
quality evidence base on NMPs’ prescribing decision-making, from the small number of 
studies it appears that the complexity identified in medical studies may be mirrored 
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always follow.  
Contexts, situations 












to avoid antibiotic 
prescribing. 
Protocols and peer 
support helpful. 
Newness of role 
resulted in some 

















Abstract: to explore 





Paper: to test the 
usefulness of patient 
scenarios in 
addressing the 
reasons why nurses 
decide whether or 
not to prescribe and 




















































(n=7) in two 









based on patient 
scenarios + self-rating 
of knowledge and 
confidence about 
medication used in 
own area of practice. 



















Most were unable to 
identify clinical 
issues and provide 
an acceptable 
solution.  Most 
claimed issues were 
out with their 
competence and 
said they would 
refer to a GP. 
All rated themselves 
‘knowledgeable’ 
about drugs 
commonly used in 
their own clinical 
areas; most felt 
confident in their 
own clinical areas. 
Most commonly 




thought and weak 
quasi-rational 
thought.  Knowledge 
(or lack of it) may 
dictate the mode of 
decision-making. 
 
 
 
Figure 1: Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) flow diagram  
(from Moher, D, Liberati, A, Tetzlaff, J, Altman DG, The PRISMA Group (2009). Preferred reporting items for systematic reviews and meta‐
analyses: the PRISMA statement. Ann Intern Med. 2009; 151(4):264‐269.) 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
Titles identified through 
database searching 
(n = 929) 
Additional titles identified 
through other sources 
(n = 0) 
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quantitative synthesis 
(meta‐analysis) 
(n = 0) 
Titles after duplicates 
removed 
(n = 886) 
Titles excluded 
(n = 537) 
Abstracts screened
(n = 349) 
Abstracts excluded 
(n = 309) 
Full‐text articles assessed 
for eligibility 
(n = 40) 
No NMP prescribing
decision‐making (n = 27) 
 
Extended formulary NP  (n = 3) 
 
Setting outwith the UK  
(n = 2) 
 
Recruitment pre‐2003   (n = 2) 
 
Studies included in 
qualitative synthesis 
(n = 3) 
 
 
 
